<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the present study was to assess <z:chebi fb="0" ids="16243">quercetin</z:chebi>'s mechanism of action in rat pial microvessels during transient bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCCAO) and reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>Rat pial microcirculation was visualized using fluorescence microscopy through a closed cranial window </plain></SENT>
<SENT sid="2" pm="."><plain>Pial arterioles were classified in five orders of branchings </plain></SENT>
<SENT sid="3" pm="."><plain>In ischemic rats, 30 min BCCAO and 60 min reperfusion caused arteriolar diameter decrease, microvascular leakage, leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in venules, and reduction of capillary perfusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="16243">Quercetin</z:chebi> highest dose determined dilation in <z:hpo ids='HP_0000001'>all</z:hpo> arteriolar orders, by 40 ± 4% of baseline in order 2 vessels, and prevented microvascular permeability [0.15 ± 0.02 normalized gray levels (NGL)], leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, and capillary failure </plain></SENT>
<SENT sid="5" pm="."><plain>Protein kinase C (PKC) inhibition exerted by chelerythrine prior to <z:chebi fb="0" ids="16243">quercetin</z:chebi> attenuated <z:chebi fb="0" ids="16243">quercetin</z:chebi>-induced effects: order 2 arterioles dilated by 19.0 ± 2.4% baseline, while there was an increase in permeability (0.40 ± 0.05 NGL) and leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> with a marked decrease in capillary perfusion </plain></SENT>
<SENT sid="6" pm="."><plain>Tyrosine kinase (TK) inhibition by tyrphostin 47 prior to <z:chebi fb="0" ids="16243">quercetin</z:chebi> lessened smaller pial arterioles responses, dilating by 20.7 ± 2.5% of baseline, while leakage increased (0.39 ± 0.04 NGL) sustained by slight leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and ameliorated capillary perfusion </plain></SENT>
<SENT sid="7" pm="."><plain>Inhibition of endothelium nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (eNOS) by N(G)-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi>-<z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>) prior to PKC or TK reduced the <z:chebi fb="0" ids="16243">quercetin</z:chebi>'s effects on pial arteriolar diameter and leakage </plain></SENT>
<SENT sid="8" pm="."><plain>eNOS inhibition by L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> reduced <z:chebi fb="0" ids="16243">quercetin</z:chebi> effects on pial arteriolar diameter and leakage </plain></SENT>
<SENT sid="9" pm="."><plain>Finally, combined inhibition of PKC and TK prior to <z:chebi fb="0" ids="16243">quercetin</z:chebi> abolished <z:chebi fb="0" ids="16243">quercetin</z:chebi>-induced effects, decreasing eNOS expression, while blocking ATP-sensitive <z:chebi fb="120" ids="26216">potassium</z:chebi> (K(ATP)) channels by <z:chebi fb="0" ids="5441">glibenclamide</z:chebi> suppressed arteriolar dilation </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, the protective effects of <z:chebi fb="0" ids="16243">quercetin</z:chebi> could be due to different mechanisms resulting in NO release throughout PKC and TK intracellular signaling pathway activation </plain></SENT>
</text></document>